Stille
205 SEK4 investors are following this company
Stille develops, manufactures, and markets medical devices for specialist surgeons. Priority areas are surgical instruments and special tables for cardiovascular surgery, gynecology, and urology. The company's products are used among users on a global level. In addition to the core business, instrument management training is also offered. Stille was originally founded in 1841 and is headquartered in Eskilstuna.
Revenue
294.89M
EBIT %
15.24 %
P/E
38.61
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
STIL
Daily low / high price
-
Market cap
1.84B SEK
Turnover
-
Volume
-
Financial calendar
General meeting
2024-05-08
Interim report
2024-07-18
Interim report
2024-10-24
Annual report
2025-02-13
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Linc AB | 22.9 % | 22.9 % |
Impilo AB | 22.9 % | 22.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Stille AB: Delårsrapport Q1 2024
Stille AB: Interim Report Q1 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools